295 related articles for article (PubMed ID: 28245428)
1. From vision to reality: deploying the immune system for treatment of sarcoma.
Wilky BA; Goldberg JM
Discov Med; 2017 Jan; 23(124):61-74. PubMed ID: 28245428
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in sarcoma: a new frontier.
Wilky BA; Goldberg JM
Discov Med; 2014 Apr; 17(94):201-6. PubMed ID: 24759624
[TBL] [Abstract][Full Text] [Related]
4. Emerging Targeted and Immune-Based Therapies in Sarcoma.
Pollack SM; Ingham M; Spraker MB; Schwartz GK
J Clin Oncol; 2018 Jan; 36(2):125-135. PubMed ID: 29220291
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell immunotherapy in soft tissue sarcoma.
Indelicato DJ; Finkelstein SE
Immunotherapy; 2012 Oct; 4(10):1023-9. PubMed ID: 23148754
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for sarcomas.
Nakata E; Fujiwara T; Kunisada T; Ito T; Takihira S; Ozaki T
Jpn J Clin Oncol; 2021 Apr; 51(4):523-537. PubMed ID: 33611603
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of sarcomas.
Goldberg JM
Curr Opin Oncol; 2013 Jul; 25(4):390-7. PubMed ID: 23736878
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic approaches to sarcoma.
Burgess M; Tawbi H
Curr Treat Options Oncol; 2015 Jun; 16(6):26. PubMed ID: 25975445
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in Sarcoma: Future Horizons.
Burgess M; Gorantla V; Weiss K; Tawbi H
Curr Oncol Rep; 2015 Nov; 17(11):52. PubMed ID: 26423769
[TBL] [Abstract][Full Text] [Related]
10. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
Zhu MMT; Shenasa E; Nielsen TO
Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
[TBL] [Abstract][Full Text] [Related]
11. Current status of immunotherapy for sarcomas.
Miwa S; Nishida H; Tsuchiya H
Immunotherapy; 2017 Dec; 9(16):1331-1338. PubMed ID: 29185391
[TBL] [Abstract][Full Text] [Related]
12. Potential for immunotherapy in soft tissue sarcoma.
Tseng WW; Somaiah N; Engleman EG
Hum Vaccin Immunother; 2014; 10(11):3117-24. PubMed ID: 25625925
[TBL] [Abstract][Full Text] [Related]
13. Future directions for immunotherapeutic intervention against sarcomas.
Maki RG
Curr Opin Oncol; 2006 Jul; 18(4):363-8. PubMed ID: 16721132
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for Soft Tissue Sarcoma: Tomorrow Is Only a Day Away.
Lee A; Huang P; DeMatteo RP; Pollack SM
Am Soc Clin Oncol Educ Book; 2016; 35():281-90. PubMed ID: 27249707
[TBL] [Abstract][Full Text] [Related]
15. The current landscape of early drug development for patients with sarcoma in the immunotherapy era.
Sebio A; Wilky BA; Keedy VL; Jones RL
Future Oncol; 2018 May; 14(12):1197-1211. PubMed ID: 29699407
[TBL] [Abstract][Full Text] [Related]
16. Sarcomas-A barren immunological wasteland or field of opportunity for immunotherapy?
Atherton MJ; Lenz JA; Mason NJ
Vet Comp Oncol; 2020 Dec; 18(4):447-470. PubMed ID: 32246517
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of immunotherapy for the treatment of sarcoma.
Klemen ND; Kelly CM; Bartlett EK
J Surg Oncol; 2021 Mar; 123(3):730-738. PubMed ID: 33259653
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of heterogenous sarcomas: questions and strategies.
Dufresne A; Meurgey A; Brahmi M
Curr Opin Oncol; 2019 Jul; 31(4):304-309. PubMed ID: 31033565
[TBL] [Abstract][Full Text] [Related]
19. Sarcomas and the immune system: implications for therapeutic strategies.
Francescutti V; Skitzki JJ
Surg Oncol Clin N Am; 2012 Apr; 21(2):341-55. PubMed ID: 22365524
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunotherapy for soft tissue sarcomas.
Finkelstein SE; Fishman M; Conley AP; Gabrilovich D; Antonia S; Chiappori A
Immunotherapy; 2012 Mar; 4(3):283-90. PubMed ID: 22401634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
